By elucidating the connections between gut health and ME/CFS, this study not only contributes to the existing body of knowledge but also seeks to empower healthcare providers to implement evidence-based strategies that could significantly enhance patient outcomes
Human trials need to define the product, route, dose, comparator, outcomes, adverse-event collection, and follow-up before those claims can be tested reliably
Mechanism Synergy Semaglutide: GLP-1 receptor agonist enhances insulin secretion, reduces appetite, delays gastric emptying
Among the several therapeutic strategies available, the use of platelet-rich plasma (PRP) and stem cell (SC) represents the mainstream technologies to repair and rejuvenate the damaged tissue caused due to injury or chronic diseases.[1] PRP is the component of the blood (plasma) which contains five times higher concentrations of platelets above the normal values, i.e., PRP is the volume of autologous plasma that has the platelet concentration above the baseline.[2] Platelets are the tiny components of blood that are rich in growth factors and play a crucial role by forming blood clots during injury
